SAN DIEGO, July 6 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE), today announced that, in accordance with NASDAQ Marketplace
Rule 4350, 37 non-officer employees were granted inducement stock options
covering an aggregate of 35,050 shares of common stock. These options were
granted pursuant to NASDAQ Marketplace Rule 4350 (i)(1)(A)(iv) with the
following terms: each option has been classified as a non-qualified stock
option, has an exercise price equal to the fair market value on the grant
date, has a ten-year term, and vests in 16 equal quarterly installments
over four years (on each quarterly anniversary of the applicable vesting
commencement date).
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in more than 50 percent of
U.S. hospitals and in more than 50 international markets. Information on
Biosite can be found at http://www.biosite.com.
Biosite(R) Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com/
http://www.prnewswire.com/comp/116737.html /
CONTACT:
Nadine Padilla, Vice President, Corporate &
Investor Relations of Biosite Incorporated, +1-858-805-2820,
npadilla@biosite.com
|
